Lexaria Bioscience receives positive test results from ready to drink CBD beverages
Lexaria Bioscience (CSE: LXX- Nasdaq: LEXXW) CEO Chris Bunka joined Steve Darling from Proactive to share news the company has released positive results from its extended stability testing for bottled CBD-containing beverages prepared using its technology.
Bunka telling Proactive Lexaria’s DehydraTECH CBD nanoemulsification formulation and processing techniques tested in beverages maintained their CBD content which was verified at 93.4% of target potency one year after production and also evidenced excellent microbial purity over this period.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE